Sharon LaFraniere
Posts
F.D.A. Stays Neutral on the Need for a Moderna Booster
An advisory panel is to vote later this week on whether to recommend emergency authorization of boosters for the Moderna and Johnson & Johnson vaccines.
Johnson & Johnson to Seek F.D.A. Authorization for Booster Shot
The request, expected this week, comes after a study found the company’s vaccine was only 71 percent effective against hospitalization from Covid-19.
F.D.A. Panel to Weigh Pfizer Shots for Children, Boosters for Moderna and Johnson & Johnson Recipients
The timing of the meetings later this month suggests that the agency plans to move quickly to decide both issues.
Novavax Says U.S. Will Pause Funding for Production of Its Vaccine
The Maryland company, which has a $1.75 billion federal contract to develop and produce a coronavirus vaccine, said it needed to address the concerns of...